Welcome to our dedicated page for Alchemy Investments Acquisition 1 Units (Proposed) SEC filings (Ticker: ALCYU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alchemy Investments Acquisition Corp 1 filings document the regulatory record of a Cayman Islands SPAC with Nasdaq-listed units, Class A ordinary shares, and warrants. The filings describe the ALCYU unit structure, including one Class A ordinary share and one-half of one redeemable warrant, and identify related trading symbols for the ordinary shares and warrants.
Its Form 8-K reports cover material-event disclosure, material agreements, capital-structure matters, shareholder voting, governance changes, amendments to organizational documents, operating and financial results, and notices involving continued-listing standards. The records also reflect emerging growth company status and SPAC security-structure disclosures tied to the blank-check company model.
Alchemy Investments Acquisition Corp 1 reported a Q1 2026 net loss of $331,900 as it continues to search for a target and close its announced merger with Cartiga.
The SPAC held $8.96 million in its Trust Account and only $86,243 in cash outside the trust, resulting in a working capital deficit of $3.91 million and substantial doubt about its ability to continue as a going concern without completing a deal.
Alchemy has a Business Combination Agreement to acquire Cartiga at an equity value of $540 million using an Up‑C structure, with closing conditioned on shareholder approvals, a Nasdaq listing and at least $40 million of available closing cash unless waived. Sponsor loans totaled $2.0 million and the company continues making monthly deposits to extend its deadline to complete a transaction to September 9, 2026.
Alchemy Investments Acquisition Corp 1 reported a Q1 2026 net loss of $331,900 as it continues to search for a target and close its announced merger with Cartiga.
The SPAC held $8.96 million in its Trust Account and only $86,243 in cash outside the trust, resulting in a working capital deficit of $3.91 million and substantial doubt about its ability to continue as a going concern without completing a deal.
Alchemy has a Business Combination Agreement to acquire Cartiga at an equity value of $540 million using an Up‑C structure, with closing conditioned on shareholder approvals, a Nasdaq listing and at least $40 million of available closing cash unless waived. Sponsor loans totaled $2.0 million and the company continues making monthly deposits to extend its deadline to complete a transaction to September 9, 2026.
Alchemy Investments Acquisition Corp 1 notified the SEC that it cannot file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 "without unreasonable effort or expense."
The company states it is working diligently and expects to file the Quarterly Report within five calendar days of the prescribed due date. The notification is signed by CEO Mattia Tomba and the filing includes SEC file number 001-41139.
Alchemy Investments Acquisition Corp 1 notified the SEC that it cannot file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 "without unreasonable effort or expense."
The company states it is working diligently and expects to file the Quarterly Report within five calendar days of the prescribed due date. The notification is signed by CEO Mattia Tomba and the filing includes SEC file number 001-41139.
Alchemy Investments Acquisition Corp 1, a special purpose acquisition company, reported that Nasdaq has determined its securities are subject to delisting for failing to comply with Nasdaq IM-5101-2. The rule requires a business combination within 36 months of the IPO registration statement, which became effective on May 4, 2023.
Because Alchemy did not complete an initial business combination by May 4, 2026, Nasdaq will suspend trading of its securities on May 14, 2026 and file Form 25-NSE to remove them from listing. The company will not appeal and expects its securities to begin trading on the over-the-counter market on May 14, 2026.
Alchemy Investments Acquisition Corp 1, a special purpose acquisition company, reported that Nasdaq has determined its securities are subject to delisting for failing to comply with Nasdaq IM-5101-2. The rule requires a business combination within 36 months of the IPO registration statement, which became effective on May 4, 2023.
Because Alchemy did not complete an initial business combination by May 4, 2026, Nasdaq will suspend trading of its securities on May 14, 2026 and file Form 25-NSE to remove them from listing. The company will not appeal and expects its securities to begin trading on the over-the-counter market on May 14, 2026.
Alchemy Investments Acquisition Corp 1 filed an amended annual report to correct the date of a prior Marcum LLP audit opinion, while re-presenting its full 2025 financial statements and SPAC disclosures.
For 2025, the SPAC reported a net loss of $1.1 million versus prior-year profit of $4.2 million, with $8.8 million held in its trust account and only $55,020 of cash outside the trust. Auditors included a going concern paragraph, citing a $3.4 million working capital deficit and reliance on completing a business combination by September 9, 2026.
The filing details a proposed Business Combination Agreement with Cartiga, LLC, valuing Cartiga at $540 million and using an Up‑C structure in which Pubco (to be renamed Cartiga Holdings, Inc.) will be the public parent and Cartiga will remain the operating partnership. Closing conditions include at least $40 million of “Available Closing Buyer Cash,” Nasdaq listing approval, and multiple shareholder and member votes. Extensive ancillary agreements, including lock‑ups, a tax receivable agreement and a shareholders agreement granting significant governance rights to key investors, would govern the post‑closing structure.
Alchemy Investments Acquisition Corp 1 filed an amended annual report to correct the date of a prior Marcum LLP audit opinion, while re-presenting its full 2025 financial statements and SPAC disclosures.
For 2025, the SPAC reported a net loss of $1.1 million versus prior-year profit of $4.2 million, with $8.8 million held in its trust account and only $55,020 of cash outside the trust. Auditors included a going concern paragraph, citing a $3.4 million working capital deficit and reliance on completing a business combination by September 9, 2026.
The filing details a proposed Business Combination Agreement with Cartiga, LLC, valuing Cartiga at $540 million and using an Up‑C structure in which Pubco (to be renamed Cartiga Holdings, Inc.) will be the public parent and Cartiga will remain the operating partnership. Closing conditions include at least $40 million of “Available Closing Buyer Cash,” Nasdaq listing approval, and multiple shareholder and member votes. Extensive ancillary agreements, including lock‑ups, a tax receivable agreement and a shareholders agreement granting significant governance rights to key investors, would govern the post‑closing structure.
Alchemy Investments Acquisition Corp 1 filed an 8-K announcing an Investor Presentation prepared with Cartiga, LLC about their potential business combination. The April 2026 presentation, attached as Exhibit 99.1, is being used to brief investors on the proposed transaction.
The filing explains that Alchemy Acquisition Holdings, Inc. intends to submit a Registration Statement on Form S-4 to the SEC, including a preliminary proxy statement/prospectus for the proposed deal. Alchemy plans to mail a definitive proxy statement and proxy card to shareholders for an Extraordinary Meeting once available.
The document includes extensive forward-looking statement and risk disclosures, highlighting uncertainties around closing the business combination, required approvals, Nasdaq listing, redemption levels and Cartiga’s growth. It clarifies that the Investor Presentation is not an offer to sell securities or a solicitation to buy or vote, and that any securities offering would only occur through a compliant prospectus or exemption.
Alchemy Investments Acquisition Corp 1 filed an 8-K announcing an Investor Presentation prepared with Cartiga, LLC about their potential business combination. The April 2026 presentation, attached as Exhibit 99.1, is being used to brief investors on the proposed transaction.
The filing explains that Alchemy Acquisition Holdings, Inc. intends to submit a Registration Statement on Form S-4 to the SEC, including a preliminary proxy statement/prospectus for the proposed deal. Alchemy plans to mail a definitive proxy statement and proxy card to shareholders for an Extraordinary Meeting once available.
The document includes extensive forward-looking statement and risk disclosures, highlighting uncertainties around closing the business combination, required approvals, Nasdaq listing, redemption levels and Cartiga’s growth. It clarifies that the Investor Presentation is not an offer to sell securities or a solicitation to buy or vote, and that any securities offering would only occur through a compliant prospectus or exemption.
Alchemy Investments Acquisition Corp. 1 filed an 8-K describing a joint press release with Cartiga, LLC about exploring a potential private investment in public equity (PIPE) to support their proposed business combination and post-closing business plan. The parties have begun preliminary talks with potential investors, but have not signed any definitive PIPE agreements and may never do so.
The press release also notes that on March 10, 2026, Cartiga completed the first closing of its new private credit vehicle, the LBS Income Fund, anchored by a subscription from a leading global alternative asset manager. Cartiga is portrayed as a data-driven legal finance platform that has deployed more than $1.9 billion into legal sector investments tied to estimated settlement values exceeding $20 billion.
Alchemy Investments Acquisition Corp. 1 filed an 8-K describing a joint press release with Cartiga, LLC about exploring a potential private investment in public equity (PIPE) to support their proposed business combination and post-closing business plan. The parties have begun preliminary talks with potential investors, but have not signed any definitive PIPE agreements and may never do so.
The press release also notes that on March 10, 2026, Cartiga completed the first closing of its new private credit vehicle, the LBS Income Fund, anchored by a subscription from a leading global alternative asset manager. Cartiga is portrayed as a data-driven legal finance platform that has deployed more than $1.9 billion into legal sector investments tied to estimated settlement values exceeding $20 billion.
Alchemy Investments Acquisition Corp 1 reported shareholder actions from its September 4, 2025 annual meeting. Investors approved a charter amendment allowing the company to extend its deadline to complete a business combination on a month-to-month basis, at the directors’ discretion, through September 9, 2026, by depositing into the trust account the lesser of $30,000 or $0.03 per non-redeemed public Class A share per month. Shareholders also ratified CBIZ CPAs P.C. as independent auditor for the fiscal year ending December 31, 2025.
Following the meeting, the company extended its business combination deadline to October 9, 2025 and deposited $22,126.29 into the trust. In connection with the vote, holders of 324,420 Class A shares elected redemption, leading to the removal of approximately $3,791,334.07 (about $11.68 per share) from the trust. After these redemptions, about $8,619,295.70 remains in the trust account, with 4,208,042 Class A shares and one Class B share outstanding.
The filing is a Form 10-Q for Alchemy Investments Acquisition Corp I (ALCYU) describing its SPAC structure, capital raised and trust mechanics. The company sold 11,500,000 Units (including a 1,500,000 overallotment) for $115,000,000 gross and placed proceeds from the IPO and Private Placement into a Trust Account to be invested in short-term U.S. government obligations or qualifying money market funds. As of June 30, 2025, investments in the Trust Account were reported at $12,252,250 (compared with $11,851,808 at year-end). Founder shares, Private Placement Shares and Public Warrants (exercise price $11.50, five-year term) and redemption mechanics (trigger at $18.00) are described. Promissory notes outstanding increased to $1,130,000 as of June 30, 2025. The Sponsor has conditional indemnity obligations to protect trust funds from certain third-party claims.
The filing excerpt describes transaction documents for Alchemy Investments Acquisition Corp 1 and related parties (ALCY, Pubco, Newco and the Company). It specifies the equity being issued as Class A Ordinary Shares with par value $0.0001 and warrants exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share.
The excerpt sets out termination rights and cure mechanics: either party may terminate the Business Combination Agreement for breaches by the other party, subject to 30-day cure periods where a breach is curable. The Company may also terminate if closing has not occurred by the 45th day after the Registration Statement is declared effective and a specified Available Closing Buyer Cash condition has not been met. The document names Mattia Tomba as Chief Executive Officer of Alchemy Investments Acquisition Corp 1.
The filing is a Form NT 10-Q notice for Alchemy Investments Acquisition Corp 1 (ALCYU) covering the period ended June 30, 2025. The registrant checked the box stating the reason described in Part III could not be eliminated without unreasonable effort or expense, and indicated the accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. The notice includes a signature block signed by Mattia Tomba, Chief Executive Officer. No earnings, financial results, or transaction details are provided in the text supplied.